Formulation and Evaluation of Benazepril Hydrochloride Transdermal Films for Controlled Drug Release
Abstract
The current research deals with formulation and evaluation of Benazepril hydrochloride transdermal films, by varying ratios of polymers Eudragit RL100, Eudragit RS100 by film casting technique. Preformulation studies were conducted to check the solubility, melting point and partition coefficient. The eleven formulations were analyzed for physicochemical parameters and drug dissolution potential of transdermal films. All the formulations are transparent with minimum weight variation and uniform thickness. The drug content uniformity of all the formulations vary between 96.84 ± 3.7% to 96.98 ± 1.6% indicate uniform drug distribution. The low water vapour transmission values indicate good water vapour permeation. The folding endurance is between 246 ± 4.60 to 315 ± 4.13 indicates that the transdermal films can withstand rupture. In vitro drug dissolution study indicates maximum amount of drug 96.8% (F2) released in 24 h when compared with marketed formulation 84.81%. The release order follows Fickian diffusion. The formulation F2 was optimized based on drug flux, permeability coefficient and enhancement ratio.
Keywords:
Benazepril Hydrochloride, Transdermal films, Hypertension, Eudragit, Plasticizer, Penetration enhancer, Permeation.DOI
https://doi.org/10.25004/IJPSDR.2019.110508References
Chien YW. Novel drug delivery systems. Drugs and the Pharmaceutical Sciences, Marcel Dekker, New York, NY, 1992; 797, pp.301-381.
Anna Wokovich M. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm. 2006;64(1):1-8.
Cleek RL, Bunge AL. A new method for estimating dermal absorption from chemical exposure. General approach. Pharm Res. 1993;l(10): 497–506.
Vinod KR, Sravani P, David Banji, Teja BB. Transdermal Drug Delivery System–Overcoming Challenges of Popular Drug Delivery Systems. IJPWR. 2010;1(3):25-32.
Vyas SP, Khar RK. Targeted and Controlled drug delivery. Edn 1, CBS, Publisher and distributors, New Delhi, 2002.
Cramer MP, Saks SR. Translating safety, efficacy and compliance into economic value for controlled release dosage forms. Pharmaco Economics 1994;5(6):482–504.
Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.Q J Med. 2002;95(9):609–19.
Mustsuo O. Skin permeability of water soluble drugs. Chem Pharma Bull. 1995;37(5): 1404-1405.
Ramesh Gannu, Vamshi Vishnu Y, Kishan V, Madhusudhan Rao Y. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. Current Drug Delivery 2007;4 (1):69-76.
Samanta MK, Dube R, Suresh B. Transdermal drug delivery system of haloperidol to overcome self induced extrapyramidal syndrome. Drug Dev Ind Pharm2003;29:405-415.
Lewis S, Pandey S, Udupa N. Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation. Ind J Pharm Sci. 2006;68:179-184.
Costa P, Ferreria DC, Morgado R, Sousa Lobo JM. Design and evaluation of a lorazepam transdermal delivery system. Drug Dev Ind Pharm. 1997;23:939-944.
Rao PR, Diwan PY. Permeability studies of cellulose acetate free films for transdermal use: Influence of plasticizers, Pharm Acta Helv. 1997;72: 47-51.
Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK. Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS Pharm SciTech. 2007;8(1):13-20.
Elias PM. Lipids and the epidermal permeability barrier. Arch Dermatol. 1981;270:95-117.
Panchagnula R, Bokalial R, Sharma P, Khandavilli S. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int J Pharm. 2005;293: 213-223.
Lewis S, Pandey S, Udupa N. Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation. Ind J Pharm Sci. 2006;68:179-184.
Sood A, Panchagnula R. Role of dissolution studies in controlled release drug delivery system. STP Pharma Sci. 1999;9:157-168.
Published
Abstract Display: 509 
PDF Downloads: 786 
